NCT04950608 2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
8 trialsNCT05847686 2025-11-05
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Phase 1/2 Completed
NCT06644170 2025-10-14
A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer
University of Washington
Phase 1 Completed
NCT05506982 2025-07-23
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Emory University
Phase 1 Completed
NCT00302744 2025-03-13
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 1/2 Completed
NCT04522804 2024-03-20
HOPE
University of Utah
Phase EARLY_PHASE1 Completed
NCT00957359 2020-10-20
Psilocybin Cancer Anxiety Study
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT00465595 2018-07-19
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Phase 2 Completed